Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determining the activity of mucosal adjuvants.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2010

Baudner Barbara C, Giudice Giuseppe Del

Abstract excerpt

Mucosal vaccination offers the advantage of blocking pathogens at the portal of entry, improving patient's compliance, facilitating vaccine delivery, and decreasing the risk of unwanted spread of infectious agents via contaminated syringes.Recent advances in vaccinology have created an array of v...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Bacterial Toxins
Share to Enterotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Escherichia coli

Share to Escherichia coli Proteins

Share to Immunity, Mucosal

Share to Mice, Inbred BALB C

Share to Vaccination

Source

Identifiers

PMID: 20099134
DOI: 10.1007/978-1-60761-585-9_18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20099134-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determining the activity of mucosal adjuvants.PMID 20099134Read ↗

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.Semantic proximity Read ↗

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide.Semantic proximity Read ↗

Non-toxic derivatives of LT as potent adjuvants.Semantic proximity Read ↗

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.Semantic proximity Read ↗

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.Semantic proximity Read ↗

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.Semantic proximity Read ↗

The role of adjuvants in the development of mucosal vaccines.Semantic proximity Read ↗

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.Semantic proximity Read ↗

Mucosal delivery of vaccines.Semantic proximity Read ↗

Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.Semantic proximity Read ↗

Escherichia coli LTB26 mutant enhances immune responses to rotavirus antigen VP8 in a mouse model.Semantic proximity Read ↗

Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.